Beals Douglas W, Barber H Dexter, Francis John R, Siu Trever, Irwin Chase, Andrews MacKenzie
Midwestern University-Arizona, College of Dental Medicine, Glendale, AZ, USA.
Manager of Bio Clinical Services, Office of Research and Sponsored Programs, Midwestern University, Glendale, AZ, USA.
J Dent Anesth Pain Med. 2025 Apr;25(2):123-132. doi: 10.17245/jdapm.2025.25.2.123. Epub 2025 Mar 27.
The inappropriate use of opioids in the United States continues to pose a significant challenge to public health. For a look into how the next generation of practitioners may be trained, this survey study sought to evaluate the current opioid prescribing patterns among Oral and Maxillofacial Surgery (OMFS) residency programs in the United States.
A 16-question survey was sent to 100 residency program directors, with responses from 27 programs. The survey aimed to assess the program's strategies for postoperative pain management, including the use of opioids, non-opioids, and other available modalities such as localized long-acting bupivacaine.
The results showed that 74% of the responding programs still taught the use of opioid prescriptions for third-molar removal, and 40% of the surveyed programs used prescription narcotics for other extractions as well. One-third of residency programs have adopted the use of localized long-lasting bupivacaine to limit the amount of narcotic medication required for dentoalveolar procedures.
This study highlights the implications of these prescription habits and raises questions regarding future improvements to OMFS resident training programs.
在美国，阿片类药物的不当使用持续对公众健康构成重大挑战。为了解下一代从业者可能如何接受培训，这项调查研究旨在评估美国口腔颌面外科（OMFS）住院医师培训项目当前的阿片类药物处方模式。
向100名住院医师培训项目主任发送了一份包含16个问题的调查问卷，收到了27个项目的回复。该调查旨在评估项目术后疼痛管理策略，包括阿片类药物、非阿片类药物以及其他可用方式（如局部长效布比卡因）的使用情况。
结果显示，74%的回复项目仍教授在拔除第三磨牙时使用阿片类药物处方，40%的被调查项目在其他拔牙手术中也使用处方类麻醉药品。三分之一的住院医师培训项目采用局部长效布比卡因来减少牙槽手术所需麻醉药物的用量。
本研究突出了这些处方习惯的影响，并对OMFS住院医师培训项目未来的改进提出了问题。
